We are live on
!
Find out more
Jazz Pharmaceuticals
JAZZ
JAZZ
461 hedge funds and large institutions have $8.82B invested in Jazz Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 75 funds opening new positions, 151 increasing their positions, 146 reducing their positions, and 59 closing their positions.
New
Increased
Maintained
Reduced
Closed
200% more funds holding in top 10
Funds holding in top 10: 3 → 9 (+6)
27% more first-time investments, than exits
New positions opened: 75 | Existing positions closed: 59
23% more call options, than puts
Call options by funds: $58.7M | Put options by funds: $47.8M
21% more capital invested
Capital invested by funds: $7.29B → $8.82B (+$1.53B)
2% more funds holding
Funds holding: 454 → 461 (+7)
3% more repeat investments, than reductions
Existing positions increased: 151 | Existing positions reduced: 146
1.87% less ownership
Funds ownership: 94.02% → 92.15% (-1.9%)
Holders
461
Holders Change
+7
Holders Change %
+1.54%
% of All Funds
7.27%
Holding in Top 10
9
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+200%
% of All Funds
0.14%
New
75
Increased
151
Reduced
146
Closed
59
Calls
$58.7M
Puts
$47.8M
Net Calls
+$10.9M
Net Calls Change
+$60.3M
Top Buyers
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$74.9M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$64.4M |
| 3 |
Millennium Management
New York
|
+$53.2M |
| 4 |
SC
Samlyn Capital
New York
|
+$41.2M |
| 5 |
ACM
Atika Capital Management
New York
|
+$28.9M |
Top Sellers
| 1 |
Boston Partners
Boston,
Massachusetts
|
-$75.7M |
| 2 |
Norges Bank
Oslo,
Norway
|
-$71.6M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$70.8M |
| 4 |
AC
Armistice Capital
New York
|
-$58.9M |
| 5 |
HM
HealthCor Management
New York
|
-$49.3M |
